The 9th Microbiome Movement Drug Development Summit returns as the industry’s trusted, definitive forum for the global network of microbial therapeutic developers. It ensures teams, like those joining from Enterobiotix, Freya Biosciences & Genome & Co can stay ahead of the curve to robustly prove clinical efficacy as regulator and investor scrutiny necessitates more compelling data than ever before.

Your only meeting dedicated to supporting business-critical networking, featuring a start-up showcase supporting the biotech industry to secure funding and progress preclinical pipelines, this is an unmissable touchpoint for developers to gain insights from live biotherapeutic and small molecule pipelines generating robust data in the clinic and improve your navigation of a fast-evolving market landscape.

Across 2 conference days, with Translational, Clinical & Manufacturing tracks, a new interactive poster session and an additional pre-conference workshop day designed for innovation scouting, strategic portfolio planning and networking with investors, join C-Level, R&D, CMC and Investor stakeholders, as 150+ innovators and thought-leaders gather under the common goal to prove the power of microbiome-altering modalities!

Event Link here.